Diagnostics
News and analysis on diagnostic technologies and applications.
BioMérieux Confirms Full-Year Growth Guidance as Q1 Sales Rise 14 Percent
First quarter sales in the company's BioFire business increased 21 percent year over year while SpotFire sales nearly tripled.
GeneDx to Offer Genome Interpretation as a Standalone Service Following Fabric Genomics Acquisition
Premium
GeneDx, which has been running a centralized lab, hopes to provide the new service to hospitals in the US and abroad that are already sequencing genomes in-house.
Cepheid, Oxford Nanopore to Broaden Use Case for Nanopore Sequencing in Infectious Disease Testing
Premium
The firms are developing a workflow that will include Cepheid's sample and library preparation, nanopore sequencing, and automated data analysis.
Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test
The company's tumor genotyping test will now be reimbursed for eligible Medicare patients under Palmetto GBA's local coverage determination for this class of assays.
The company's Prostox germline microRNA-based assay predicted late-onset toxicity following radiation therapy and helped to identify biological pathways involved.